Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q1 EPS of ($0.31), $0.11 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.